The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Funding Opportunity Number:
Mar 25, 2011
Mar 25, 2011
Original Closing Date for Applications:
May 25, 2011
Current Closing Date for Applications:
May 25, 2011
Jun 24, 2011
Funding Instrument Type:
Category of Funding Activity:
Expected Number of Awards:
Estimated Total Program Funding:
The Affordable Care Act: Human Immunodeficiency Virus (HIV) Prevention and Public Health Fund Activities
Cost Sharing or Matching Requirement:
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Applicants eligible to apply for this cooperative agreement are limited to twelve (12) entities in specific Metropolitan Statistical Areas (MSAs) or specified Metropolitan Divisions (MDs) that have the highest estimated AIDS prevalence at the end of 2007. These twelve eligible areas received funding for Phase I of the project under announcement CDC-RFA-PS10-10181. The entities eligible to apply for funds under this FOA are as follows:
1. New York City Department of Health and Mental Hygiene
2. Los Angeles County Public Health Department
3. District of Columbia Department of Health
4. Chicago Department of Public Health
5. Georgia Department of Human Resources
6. Florida State Department of Health
7. City of Philadelphia Public Health Department
8. Houston Department of Health and Human Services
9. San Francisco Department of Public Health
10. Maryland State Department of Health
11. Texas State Department of Health Services
12. Puerto Rico Department of Health
Centers for Disease Control and Prevention
This announcement supports integration of diagnostic and prevention services for the Human Immunodeficiency Virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), sexually transmitted diseases (STD); and tuberculosis (TB) because of CDC's greater understanding of the extent to which:
• STDs increase the risk for HIV infection.
• Control of TB, viral hepatitis, and STDs is needed to protect the health of HIV-infected persons.
• HIV, viral hepatitis and STDs share common risks and modes of transmission.
• Risks for acquiring theses diseases are associated with similar behaviors and environmental conditions and have reciprocal or interdependent effects.
• Clinical course and outcomes of these diseases are influenced by co-infection (for example, HIV/TB can be deadly, and TB accelerates HIV disease progression).
• Populations disproportionately affected by HIV are also disproportionately affected by infections with TB, HCV, HBV, and STDs.